http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2748074-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f848766416af24d6a445ab51dbf5ba99
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
filingDate 2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f613dd93d6fc1a1519cc9010e1120e7
publicationDate 2020-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2748074-A1
titleOfInvention PROCESS OF OBTAINING TYPE II COLLAGEN NATIVE OF AVIAN ORIGIN
abstract Process of obtaining native type II collagen of avian origin. The invention relates to a process for obtaining native type II collagen from chicken cartilage useful for preventing or alleviating symptoms of rheumatoid arthritis in humans and in mammals in general. The process details the characteristics to obtain said material, its sanitization, drying and grinding, to be able to be used in a safe way in food supplements. The process generates a microbiologically harmless product, free of pathogens, which can be safely dosed for consumption in formulations.
priorityDate 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 20.